Real-time enrollment status for this advanced cancer clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 12:45 PM UTC
| NCT Number | NCT06581432 |
| Recruiting Status | Recruiting |
| Condition | Advanced Cancer |
| Phase | PHASE2 |
| Target Enrollment | 430 participants |
| Active Locations | 20 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 7, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06581432 is currently recruiting participants. This phase2 study for advanced cancer is actively seeking new participants at 20 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06581432 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 20 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06581432 was last updated 1 week ago (July 7, 2026). HelloStudys verifies this status automatically.